Clinical trial

Safety and Effectiveness of the XEN45 Glaucoma Treatment System in Patients With Angle Closure Glaucoma

NCT03362931

Study summary

ClinicalTrials.gov

Safety and Effectiveness of the XEN45 Glaucoma Treatment System in Patients With Angle Closure Glaucoma

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DEVICE · Unmapped registry intervention XEN45 Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2018-07-19

PhasePHASE3

Conditions

Glaucomaverified · MONDO: glaucoma

Angle-Closureunresolved

Interventions

XEN45DEVICE

Sponsors & collaborators

Allerganlead sponsor

Mapped research locations

SingaporeSingapore2 SeoulSouth Korea1 MontrealQuebec, Canada1 EdinburghUnited Kingdom1 FitzroyVictoria, Australia1 ColchesterUnited Kingdom1 ManchesterLancashire, United Kingdom1 MississaugaCanada1 ParramattaNew South Wales, Australia1 GuildfordEngland, United Kingdom1 Hualien CityHualien, Taiwan1 BoisbriandQuebec, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03362931 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.